Drugs - Drugs Xagena

Drugs

Home Page

Xagena Medicine

Xagena.net

Wet age-related macular degeneration: FDA has approved Lucentis

Parkinson’s disease: Exelon for treatment of dementia

HIV-1 infection: FDA has approved Atripla, an once-a-day three-drug combination

Wet age-related macular degeneration: FDA has approved Lucentis

Bismacine may cause serious adverse events

Thrombolitic therapy before angioplasty or stent placement not beneficial for myocardial infarction patients

Morphine and topical Tetracaine found effective in treating pain in newborn infants

Sensible metabolic differences in how adults, infants and children process drugs

Raloxifene as effective as Tamoxifen in preventing invasive breast cancer

NICE: inhaled Insulin is not recommended for the treatment of type 1 or type 2 diabetes mellitus ( preliminary recommendations )

FDA has approved Dacogen for treatment of myelodysplastic syndromes

EU: Herceptin for early-stage in HER2-positive breast cancer approved

Relapsing multiple sclerosis: FDA has approved the reintroduction of Tysabri

FDA has approved Sprycel in chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia, with resistance to prior therapy

Boxed warning about a possible risk of cancer for two eczema drugs, Elidel and Protopic

Antibiotic Telithromycin linked to severe hepatotoxicity

Gastrointestinal and kidney cancer: FDA has approved Sunitinib

Exubera, an inhaled powder form of recombinant human insulin, approved by FDA

Tamiflu prescribed concurrently with Warfarin: suspected increase in INR

Antidepressants linked to increased risk of persistent pulmonary hypertension in newborns

Pregnancy: newer antidepressants linked to persistent pulmonary hypertension in newborns

Galantamine appears to protect against nerve agents

Methylphenidate patch to treat attention deficit hyperactivity disorder in children, approved

Prograf to prevent rejection of heart transplant, approved

Relenza for the prevention of influenza A and B in adults and children

Head and neck cancer: treatment with Erbitux extends survival

Emsam is the first transdermal patch for depression

Vivitrol for treatment of alcohol-dependent patients, approved

Macugen: rare cases of anaphylaxis/anaphylactoid reactions

Sepsis associated with Mifeprex for medical abortion

Next Pages 1 2 3 4 5 6 [7] 8 9 10

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions